GMAB logo

Genmab A/S (GMAB) Return On Equity

Annual ROE:

23.26%+8.57%(+58.34%)
December 31, 2024

Summary

  • As of today, GMAB annual return on equity is 23.26%, with the most recent change of +8.57% (+58.34%) on December 31, 2024.
  • During the last 3 years, GMAB annual ROE has risen by +8.63% (+58.99%).
  • GMAB annual ROE is now -21.39% below its all-time high of 29.59%, reached on December 31, 2016.

Performance

1-Year Change

+58.34%

3-Year Change

+58.99%

5-Year Change

+19.53%

15-Year Change

+17.89%

GMAB ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

86.89%
GMAB annual return on equity is higher than 86.89% of companies in Healthcare sector

Range

All-Time High

29.59%
GMAB annual return on equity is currently -21.39% below its historical high of 29.59%

3-Year Low

14.63%
GMAB annual return on equity is currently +58.99% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
GMAB previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
GMAB next annual earnings announcement has not yet been scheduled

OtherGMABprofitability metrics

Annual Revenue

$3.12B
GMAB annual revenue is $3.12 billion

Annual Net Income

$1.14B
GMAB annual net profit is $1.14 billion

Annual EPS

$1.76
GMAB annual earnings per share is $1.76

Annual ROA

19.63%
GMAB annual return on assets is 19.63%

Quarterly ROE:

25.51%+2.19%(+9.39%)
June 1, 2025

Summary

  • As of today, GMAB quarterly return on equity is 25.51%, with the most recent change of +2.19% (+9.39%) on June 1, 2025.
  • Over the past year, GMAB quarterly ROE has increased by +7.81% (+44.12%).
  • GMAB quarterly ROE is now -38.94% below its all-time high of 41.78%, reached on June 30, 2020.

Performance

3-Month Change

+9.39%

1-Year Change

+44.12%

3-Year Change

+44.7%

5-Year Change

-38.94%

GMAB Quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

86.06%
GMAB quarterly return on equity is higher than 86.06% of companies in Healthcare sector

Range

All-Time High

41.78%
GMAB quarterly return on equity is currently -38.94% below its historical high of 41.78%

3-Year Low

14.65%
GMAB quarterly return on equity is currently +74.13% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 1, 2025
GMAB previous earnings announcement was published on Jun 1, 2025

Next Quarterly Earnings Report Date

Nov 6, 2025
GMAB next earnings announcement is scheduled for Nov 6, 2025

OtherGMABprofitability metrics

Quarterly Revenue

$936.73M
GMAB quarterly revenue is $936.73 million

Quarterly Net Income

$340.26M
GMAB quarterly net profit is $340.26 million

Quarterly EPS

$0.55
GMAB quarterly earnings per share is $0.55

Quarterly ROA

20.58%
GMAB quarterly return on assets is 20.58%

ROE Formula

ROE =  Net Income
Shareholders Equity ✕ 100%

Annual ROE

23.26%
GMAB annual return on equity is 23.26%

Annual Net Income

$1.14B
GMAB annual net profit is $1.14 billion

Annual Shareholders Equity

$5.10B
GMAB annual stockholders equity is $5.10 billion

GMAB ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+58.3%+44.1%
3Y3 Years+59.0%+44.7%
5Y5 Years+19.5%-38.9%

GMAB ROE Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Yearat high+59.0%at high+74.1%
5Y5-Year-16.0%+59.0%-29.2%+127.2%
All-TimeAll-Time-21.4%+165.5%-38.9%+164.5%

GMAB ROE History

DateAnnualQuarterly
Jun 2025
-
25.51%(+9.4%)
Mar 2025
-
23.32%(-2.3%)
Dec 2024
23.26%(+58.3%)
23.87%(+62.9%)
Sep 2024
-
14.65%(-17.2%)
Jun 2024
-
17.70%(-1.1%)
Mar 2024
-
17.90%(+21.4%)
Dec 2023
14.69%(-30.3%)
14.74%(-3.6%)
Sep 2023
-
15.29%(-11.1%)
Jun 2023
-
17.19%(-14.2%)
Mar 2023
-
20.03%(-8.1%)
Dec 2022
21.08%(+44.1%)
21.80%(-7.0%)
Sep 2022
-
23.44%(+33.0%)
Jun 2022
-
17.63%(+57.0%)
Mar 2022
-
11.23%(-23.7%)
Dec 2021
14.63%(-47.2%)
14.71%(+0.6%)
Sep 2021
-
14.62%(+9.8%)
Jun 2021
-
13.31%(-56.2%)
Mar 2021
-
30.36%(+10.2%)
Dec 2020
27.70%(+42.3%)
27.54%(-23.5%)
Sep 2020
-
36.02%(-13.8%)
Jun 2020
-
41.78%(+103.6%)
Mar 2020
-
20.52%(-2.4%)
Dec 2019
19.46%(-6.5%)
21.03%(+20.9%)
Sep 2019
-
17.40%(+14.4%)
Jun 2019
-
15.21%(-16.6%)
Mar 2019
-
18.24%(-12.9%)
Dec 2018
20.81%(+5.5%)
20.93%(-5.2%)
Sep 2018
-
22.08%(+8.6%)
Jun 2018
-
20.33%(-9.1%)
Mar 2018
-
22.36%(+7.6%)
Dec 2017
19.73%(-33.3%)
20.78%(-8.9%)
Sep 2017
-
22.80%(-21.9%)
Jun 2017
-
29.19%(+1.5%)
Mar 2017
-
28.75%(-4.7%)
Dec 2016
29.59%(+9.2%)
30.17%(+46.5%)
Sep 2016
-
20.59%(+0.0%)
Jun 2016
-
20.58%(+19.5%)
Mar 2016
-
17.22%(-36.8%)
Dec 2015
27.09%(+14.3%)
27.25%(+52.8%)
Sep 2015
-
17.83%(-16.3%)
Jun 2015
-
21.31%(+5.1%)
Mar 2015
-
20.27%(+8.6%)
Dec 2014
23.71%(+79.9%)
18.67%(-15.6%)
Sep 2014
-
22.11%(+66.7%)
Jun 2014
-
13.26%(-26.1%)
Mar 2014
-
17.95%(+27.2%)
Dec 2013
13.18%(+152.3%)
14.11%(+1617.2%)
Sep 2013
-
-0.93%(+92.5%)
Jun 2013
-
-12.40%(-161.1%)
Mar 2013
-
-4.75%(+82.2%)
Dec 2012
-25.19%
-26.75%(+9.1%)
Sep 2012
-
-29.42%(-71.3%)
Jun 2012
-
-17.17%(+35.4%)
DateAnnualQuarterly
Mar 2012
-
-26.57%(+4.8%)
Dec 2011
-28.83%(-152.0%)
-27.90%(+1.7%)
Sep 2011
-
-28.38%(-118.6%)
Jun 2011
-
-12.98%(-10.8%)
Mar 2011
-
-11.72%(+3.1%)
Dec 2010
-11.44%(+42.2%)
-12.09%(-154.9%)
Sep 2010
-
22.02%(+301.1%)
Jun 2010
-
5.49%(+151.8%)
Mar 2010
-
2.18%(+219.8%)
Dec 2009
-19.80%(+40.1%)
-1.82%(+95.2%)
Sep 2009
-
-37.65%(-15.2%)
Jun 2009
-
-32.67%(+13.9%)
Mar 2009
-
-37.95%(-3.2%)
Dec 2008
-33.08%(-98.1%)
-
Dec 2008
-
-36.78%(-48.8%)
Sep 2008
-
-24.72%(+13.3%)
Jun 2008
-
-28.52%(-58.5%)
Mar 2008
-
-17.99%(-27.2%)
Dec 2007
-16.70%(+48.2%)
-
Dec 2007
-
-14.14%(+10.9%)
Sep 2007
-
-15.87%(-8.8%)
Jun 2007
-
-14.58%(+29.2%)
Mar 2007
-
-20.59%(+24.5%)
Dec 2006
-32.23%(+3.3%)
-
Dec 2006
-
-27.28%(-4.7%)
Sep 2006
-
-26.05%(+4.6%)
Jun 2006
-
-27.31%(+11.8%)
Mar 2006
-
-30.95%(+10.4%)
Dec 2005
-33.34%(+6.1%)
-
Dec 2005
-
-34.54%(+5.8%)
Sep 2005
-
-36.66%(+4.8%)
Jun 2005
-
-38.52%(+2.6%)
Mar 2005
-
-39.55%(-4.4%)
Dec 2004
-35.52%(-35.0%)
-
Dec 2004
-
-37.89%(+0.8%)
Sep 2004
-
-38.19%(+1.5%)
Jun 2004
-
-38.77%(-39.6%)
Mar 2004
-
-27.77%(-5.9%)
Dec 2003
-26.32%(+13.6%)
-
Dec 2003
-
-26.23%(+7.0%)
Sep 2003
-
-28.19%(-11.5%)
Jun 2003
-
-25.28%(+17.6%)
Mar 2003
-
-30.69%(-4.0%)
Dec 2002
-30.45%(-200.6%)
-
Dec 2002
-
-29.51%(-39.3%)
Sep 2002
-
-21.19%(-15.4%)
Jun 2002
-
-18.37%(-23.7%)
Mar 2002
-
-14.85%(-57.5%)
Dec 2001
-10.13%(-176.8%)
-9.43%(-116.8%)
Sep 2001
-
-4.35%(-171.9%)
Jun 2001
-
-1.60%(>-9900.0%)
Mar 2001
-
-0.01%
Dec 2000
-3.66%(+85.0%)
-
Dec 1999
-24.34%
-

FAQ

  • What is Genmab A/S annual return on equity?
  • What is the all-time high annual ROE for Genmab A/S?
  • What is Genmab A/S annual ROE year-on-year change?
  • What is Genmab A/S quarterly return on equity?
  • What is the all-time high quarterly ROE for Genmab A/S?
  • What is Genmab A/S quarterly ROE year-on-year change?

What is Genmab A/S annual return on equity?

The current annual ROE of GMAB is 23.26%

What is the all-time high annual ROE for Genmab A/S?

Genmab A/S all-time high annual return on equity is 29.59%

What is Genmab A/S annual ROE year-on-year change?

Over the past year, GMAB annual return on equity has changed by +8.57% (+58.34%)

What is Genmab A/S quarterly return on equity?

The current quarterly ROE of GMAB is 25.51%

What is the all-time high quarterly ROE for Genmab A/S?

Genmab A/S all-time high quarterly return on equity is 41.78%

What is Genmab A/S quarterly ROE year-on-year change?

Over the past year, GMAB quarterly return on equity has changed by +7.81% (+44.12%)
On this page